Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 20
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Eur Acad Dermatol Venereol ; 31(2): 260-266, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27453064

RESUMEN

BACKGROUND: Actinic keratosis (AK) is a cutaneous intraepithelial neoplasm that typically develops on sun-damaged skin. The incidence of AK is increasing worldwide, and it is accepted as the most frequent pre-malignant lesion in humans. OBJECTIVES: To demonstrate that ingenol mebutate gel is effective in the treatment of actinic keratoses because of its clinical, dermoscopic, capillaroscopic, histopathological and immunohistochemical treatment outcomes. METHODS: Sixty individuals with multiple non-hypertrophic AKs were enrolled into this non-randomized, open-label, prospective, trial. Acquisition of clinical, dermoscopic and capillaroscopic images at baseline (T0), immediately after treatment on 3rd (trunk and/or extremities) or 4th (scalp and/or face) day (T1), 14 days after the end of the treatment (T2) and at 60 days (T3). A subgroup of 20 patients received a cutaneous biopsy both at baseline and at T3 for histological and immunohistochemical evaluation. RESULTS: Clinical improvement was observed in 100% of cases: total clearance in 41 patients (68.3%); partial clearance in 19 patients (32.7%). After treatment, dermoscopic improvement of all non-pigmented and pigmented AK lesions was observed. Most of the dermoscopic features disappeared with treatment. Total disappearance of specific vascular structures or significant reduction in the number and calibre of new blood vessels was capillaroscopically observed in all patients analysed (P ≤ 0.001). The immunohistochemical expression of p63 (P = 0.002), Ki-67 (P = 0.015) and VEGF (P = 0.016) significantly decreased. CONCLUSIONS: The clinical efficacy of ingenol mebutate on AKs is confirmed by its effect on angiogenesis, stem cell activity and cell proliferation in vivo.


Asunto(s)
Dermoscopía/métodos , Diterpenos/uso terapéutico , Queratosis Actínica/tratamiento farmacológico , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Inmunohistoquímica , Queratosis Actínica/metabolismo , Masculino , Persona de Mediana Edad , Estudios Prospectivos
2.
Dermatol Ther ; 29(5): 325-329, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27364361

RESUMEN

Granuloma faciale (GF) is a rare chronic inflammatory dermatosis of unknown etiology, characterized by leukocitoclastic vasculitis usually occurring on the face. We report a case of 60-years-old man with 3 year history of multiple actinic keratoses (AK) and persistent asymptomatic erythematous papules and plaques located over his left temporal region and the cheek: histopathology was consistent with GF. Herein we describe the successful treatment of the lesion with ingenol mebutate 0.015% gel focusing on the clinical, dermoscopic and histopathological findings of GF both before and after treatment.


Asunto(s)
Fármacos Dermatológicos/uso terapéutico , Diterpenos/uso terapéutico , Dermatosis Facial/tratamiento farmacológico , Granuloma/tratamiento farmacológico , Queratosis Actínica/tratamiento farmacológico , Piel/efectos de los fármacos , Administración Cutánea , Biopsia , Fármacos Dermatológicos/administración & dosificación , Dermoscopía , Diterpenos/administración & dosificación , Dermatosis Facial/diagnóstico , Geles , Granuloma/diagnóstico , Humanos , Queratosis Actínica/diagnóstico , Masculino , Persona de Mediana Edad , Inducción de Remisión , Piel/patología , Resultado del Tratamiento
3.
G Ital Dermatol Venereol ; 150(4): 467-71, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25394212

RESUMEN

Toxic epidermal necrolysis (TEN), also known as Lyell syndrome, is a potential life-threatening muco-cutaneous disease with important systemic implications. It affects the skin and mucous membranes, with involvement of more than 30% of body surface and it is mostly caused by drugs. Although the pathogenesis is not fully elucidated, it is probably linked to the inability to detoxicate reactive metabolites of drugs, to genetic susceptibility and to immune factors leading to cellular apoptosis. Currently, there are no randomized control trials and stardardized therapeutical approaches for the management of Lyell syndrome; therefore controversial clinical responses to the most common used drug in TEN make it difficult for the clinical-therapeutic approach. The authors reported their experience on three patients affected by Lyell syndrome treated with infliximab.


Asunto(s)
Fármacos Dermatológicos/uso terapéutico , Infliximab/uso terapéutico , Síndrome de Stevens-Johnson/tratamiento farmacológico , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Membrana Mucosa/patología , Piel/patología , Síndrome de Stevens-Johnson/patología , Resultado del Tratamiento
5.
J Eur Acad Dermatol Venereol ; 20(10): 1220-5, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17062035

RESUMEN

BACKGROUND: Merkel cell carcinoma (MCC) is a rare, aggressive cancer of the skin that mainly affects elderly patients. Because of its rarity, there is no established treatment or proven markers to guide therapy or prognosis. Immunohistochemical expression of apoptosis proteins is considered a useful marker of both malignancy and tumour progression. Apoptosis plays a fundamental role in skin homeostasis, and apoptotic cells have been detected in normal and diseased skin. Chemokines possess a wide range of biological activities and CXCR4 is expressed in some cancer cells, where it plays an efficient role in metastasis formation. OBJECTIVE: To identify immunohistochemical parameters that can help clinicians select the most suitable therapy for skin MCC. DESIGN: Antibodies against ki67, bcl-2, p53, survivin, p16 and CXCR4 were tested to assess the usefulness of these antigens as indices of proliferation potential and predictors of prognosis. METHODS: Immunohistochemical detection of apoptosis inhibitors and CXCR4 was performed on tissue from 12 patients with primary MCC. After excision of the primary lesion, five survived and had no metastases, and seven experienced local recurrence or lymph node metastases. RESULTS: Expression of ki67 and survivin was increased in patients with local recurrence or metastasis (retrospectively classified as 'poor prognosis') compared with those with a 'good prognosis', and bcl-2 expression was significantly greater (P=0.003). P53 and p16 immunostaining was moderate in both groups. A positive correlation was observed between survivin and mutant p53 in the poor prognosis group (r=0.593, P=0.033; regression coefficient). High values of p53 were measured in patients with high levels of survivin and vice versa. CXCR4 was not detected at all. CONCLUSIONS: Our results show strong MCC cell apoptosis inhibition and a high cell proliferation capacity. The positive correlation between survivin and p53 may be a predictor of MCC spread via the lymphatic network. Absent CXCR4 expression may reflect a less aggressive form, with less efficient development of distant and non-organ-selective metastasis formation.


Asunto(s)
Apoptosis , Carcinoma de Células de Merkel/metabolismo , Carcinoma de Células de Merkel/patología , Receptores CXCR4/metabolismo , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/patología , Biomarcadores/metabolismo , Biomarcadores de Tumor/metabolismo , División Celular , Inhibidor p16 de la Quinasa Dependiente de Ciclina/metabolismo , Humanos , Inmunohistoquímica , Proteínas Inhibidoras de la Apoptosis , Antígeno Ki-67/metabolismo , Proteínas Asociadas a Microtúbulos/metabolismo , Proteínas de Neoplasias/metabolismo , Valor Predictivo de las Pruebas , Pronóstico , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Survivin , Proteína p53 Supresora de Tumor/metabolismo
6.
J Eur Acad Dermatol Venereol ; 19(6): 732-6, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16268881

RESUMEN

We present a case of an intriguing mesenchymal neoplasm of the scalp that recurred several times over 10 years before a final diagnosis was possible. The case was sent for expert opinions to various international dermatopathological authorities and was, for a long time, unanimously interpreted as malignant melanoma. This diagnosis was supported by immunohistochemical examinations demonstrating S-100 positivity. Nevertheless, the clinical behaviour, as well as some histopathological features raised doubt regarding the diagnosis. Only after the last recurrence, followed by a repeat extensive immunohistochemical study, the diagnosis of epithelioid angiosarcoma was made. Histologically malignant melanoma can be highly misleading and in literature, reports of misinterpreted cases of melanoma are published. In contrast, tumours that can simulate melanoma are also not infrequent and it is essential to perform immunohistochemistry to confirm diagnosis and exclude a melanocytic lesion.


Asunto(s)
Neoplasias de Cabeza y Cuello/diagnóstico , Hemangiosarcoma/diagnóstico , Cuero Cabelludo/patología , Neoplasias Cutáneas/diagnóstico , Diagnóstico Diferencial , Femenino , Neoplasias de Cabeza y Cuello/patología , Hemangiosarcoma/patología , Humanos , Melanoma/diagnóstico , Persona de Mediana Edad , Neoplasias Cutáneas/patología
8.
Urol Int ; 70(3): 227-31, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12660463

RESUMEN

A 43-year-old Albanian man is presented who underwent nephrectomy for a huge right spontaneous perirenal hematoma. The diagnosis of polyarteritis nodosa as the etiology of the hematoma has been made only by histological examination, because of the quick and unforeseeable onset of this complication and the nonspecificity of symptoms. We hypothesize a relationship between reactivation of polyarteritis nodosa and treatment with rifampicin and isoniazid.


Asunto(s)
Hematoma/etiología , Hipertensión Renal/etiología , Enfermedades Renales/etiología , Poliarteritis Nudosa/complicaciones , Adulto , Antituberculosos/uso terapéutico , Humanos , Isoniazida/uso terapéutico , Riñón/patología , Masculino , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Nefrectomía , Rifampin/uso terapéutico
9.
Lupus ; 12(1): 63-6, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12587829

RESUMEN

We report on a case of 40-year-old female with systemic lupus erythematosus (SLE) who developed a severe bullous eruption on sun-exposed areas. The bullous manifestation was associated with a flare of lupus serologies, whereas the previous manifestations of the disease were quiescent. Due to prior intolerance to many drugs, she was given oral methotrexate (10 mg/week). The drug administration was followed by a rapid and full resolution of cutaneous lesions. Five months later she developed a class III lupus nephritis. Our case is the first report of efficacy of methotrexate in bullous SLE and rises the question of the relationship between bullous eruption and SLE activity.


Asunto(s)
Fármacos Dermatológicos/administración & dosificación , Lupus Eritematoso Sistémico/tratamiento farmacológico , Metotrexato/administración & dosificación , Enfermedades Cutáneas Vesiculoampollosas/tratamiento farmacológico , Administración Oral , Adulto , Femenino , Humanos , Lupus Eritematoso Sistémico/patología , Nefritis Lúpica/tratamiento farmacológico , Nefritis Lúpica/patología , Enfermedades Cutáneas Vesiculoampollosas/patología
10.
Br J Dermatol ; 146(5): 877-81, 2002 May.
Artículo en Inglés | MEDLINE | ID: mdl-12000388

RESUMEN

We report a 22-year-old woman who developed systemic lupus erythematosus (SLE) immediately after an Epstein-Barr virus (EBV)-induced mononucleosis infection. The link between these two conditions has long been suspected. The close temporal relationship, the course of the pathological events and the development of immunological changes in this case provide further evidence supporting the hypothesis that EBV infection could work as a trigger in some cases of SLE, particularly if the patient is genetically susceptible.


Asunto(s)
Mononucleosis Infecciosa/complicaciones , Lupus Eritematoso Sistémico/virología , Enfermedad Aguda , Adulto , Autoanticuerpos/sangre , Femenino , Humanos , Lupus Eritematoso Sistémico/inmunología , Lupus Eritematoso Sistémico/patología
11.
J Cutan Pathol ; 28(3): 120-6, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11168762

RESUMEN

BACKGROUND: Metalloproteinases (MMPs) are thought to be involved in the process of destruction of basement membranes and stromal invasion by neoplastic epithelial cells. AIMS: In order to investigate the role of MMPs in cutaneous oncogenesis we studied the expression of MMP-2 and MMP-9 in 34 cases of epidermal preinvasive neoplastic lesions and invasive carcinomas. We also studied their relationship with the expression of tissue inhibitors of MMPs and with proliferative activity and p53 expression in neoplastic epithelial cells. RESULTS: MMP-9 was found to be focally expressed by neoplastic epithelial cells at the infiltrative edges in microinvasive carcinomas and in dyskeratotic foci in Bowen's disease and widely invasive carcinomas. Gradation of Mib-1 positivity and p53 expression was found with increasing abnormality in the spectrum of malignancy. CONCLUSIONS: Our results seem to suggest the involvement of MMPs in microinvasive carcinomas, which show also low proliferative activity and p53 expression, whether other factors seem to be more important in widely invasive carcinomas.


Asunto(s)
Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Neoplasias Cutáneas/patología , Proteína p53 Supresora de Tumor/biosíntesis , Anciano , Anciano de 80 o más Años , Antígenos Nucleares , Enfermedad de Bowen/enzimología , Enfermedad de Bowen/patología , División Celular , Humanos , Inmunohistoquímica , Antígeno Ki-67 , Metaloproteinasa 2 de la Matriz/análisis , Metaloproteinasa 9 de la Matriz/análisis , Persona de Mediana Edad , Invasividad Neoplásica , Proteínas Nucleares/análisis , Neoplasias Cutáneas/enzimología , Inhibidor Tisular de Metaloproteinasa-1/análisis , Inhibidor Tisular de Metaloproteinasa-2/análisis , Proteína p53 Supresora de Tumor/análisis
12.
Br J Dermatol ; 143(5): 974-8, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11069505

RESUMEN

BACKGROUND: The dermal and perivascular infiltrate in dermatitis herpetiformis (DH), which is mainly composed of CD4+ lymphocytes, neutrophils and eosinophils, is believed to play an important part in the pathogenesis of the disease. Previous studies suggest that cytokines such as interleukin (IL) -8, granulocyte-macrophage colony-stimulating factor, IL-4 and IL-5 could be involved in the pathogenesis of DH. These cytokines appear to drive tissue infiltration and maturation of eosinophils. Part of the effect of T-helper (Th) 2-type cytokines (IL-4, IL-5) on eosinophils could be mediated by eotaxin, which is a highly specific chemotactic protein induced by various cytokines [IL-4, IL-13, tumour necrosis factor (TNF) -alpha and interferon-gamma]. OBJECTIVES: To evaluate the expression of eotaxin and its inducers, IL-13 and TNF-alpha, in DH. METHODS We examined lesions collected from 10 DH patients with active disease. Sections from each specimen were incubated with anti-IL-13, anti-TNF-alpha and anti-eotaxin antibodies. Chloroacetyl esterase reaction was performed to show mast cell infiltration. RESULTS: Eotaxin was mainly expressed at the tips of the dermal papillae, within the microabscesses. Positivity was also found in the lymphomonocytic infiltrate in the dermis. IL-13 was expressed in the dermal infiltrate and TNF-alpha was found in the inflammatory infiltrate and in dermal vascular cells. CONCLUSIONS: These findings confirm the importance of the lymphomonocytic infiltrate and of Th2 cytokines in the pathogenesis of this disease, suggesting that tissue infiltration in DH is mediated by cell-specific chemokines such as eotaxin and not only by non-specific chemokines such as IL-8.


Asunto(s)
Quimiocinas CC , Citocinas/metabolismo , Dermatitis Herpetiforme/metabolismo , Interleucina-13/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Adulto , Quimiocina CCL11 , Femenino , Humanos , Técnicas para Inmunoenzimas , Masculino , Persona de Mediana Edad , Piel/metabolismo
14.
Am J Dermatopathol ; 22(3): 264-7, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10871072

RESUMEN

We describe two cases of adult rhabdomyoma. One was located in the lip of a 66-year-old woman and was removed because it was clinically suspicious for infiltrating carcinoma. The other arose in the eyelid of a 60-year-old woman with a glass eye and was initially interpreted as a reactive process due to the prosthesis. Both lesions were composed of cells with oval nuclei and deeply eosinophilic cytoplasms with occasional cross striations. Immunoreactivity for desmin and myoglobin excluded the diagnosis of other tumors with similar morphology. The unusual association of the eyelid tumor with the prosthesis suggests a role for chronic irritation in the pathogenesis of rhabdomyoma.


Asunto(s)
Neoplasias de los Párpados/patología , Neoplasias de los Labios/patología , Rabdomioma/patología , Neoplasias Cutáneas/patología , Anciano , Biomarcadores de Tumor/análisis , Neoplasias de los Párpados/química , Neoplasias de los Párpados/cirugía , Femenino , Humanos , Técnicas para Inmunoenzimas , Neoplasias de los Labios/química , Neoplasias de los Labios/cirugía , Persona de Mediana Edad , Proteínas de Neoplasias/análisis , Rabdomioma/química , Rabdomioma/cirugía , Neoplasias Cutáneas/química , Neoplasias Cutáneas/cirugía
15.
Haematologica ; 84(9): 809-13, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10477454

RESUMEN

BACKGROUND AND OBJECTIVE: The early stages of mycosis fungoides (MF) can be treated but not cured by photochemotherapy (PUVA) alone; some recent studies of the effect of a combination of human interferon-alpha (IFN(alpha)) and PUVA reported a high degree of response. The aim of our study was to evaluate the activity of a low dose of IFN-alpha2b combined with PUVA. DESIGN AND METHODS: Twenty-five patients were included: 16 men and 9 women aged between 23-80 years; 19 patients ahd stage I and 6 stage II disease. In the induction phase, the dose of IFNalpha was gradually raised over 6-8 weeks to the target dose of 18 MU/week; in the maintenance phase, the combination with PUVA allowed IFNalpha to be reduced to a maximum dose of 6 MU/week; in this way the cumulative administration of IFNalpha and PUVA was considerably lower than in similar combination protocols. Treatment success was analyzed in terms of freedom from treatment failure (FFTF). RESULTS: After the induction phase 9/25 patients (36%) achieved complete remission (CR) and 15/25 (56%) achieved partial remission (PR). One to five months from the beginning of the maintenance phase, a CR was recorded in 19/25 patients (76%) and a PR in 5/25 patients (20%) accounting for an overall response rate of 96%. The median of FFTF was not reached; probability of FFTF was 82% at 12 months and 62% at 24 months. Disease free survival projected to 48 months was 75%. INTERPRETATION AND CONCLUSIONS: Even with low doses of IFNalpha plus PUVA it is possible to achieve excellent clinical responses,many of which are long-lasting, in patients with early MF.


Asunto(s)
Antineoplásicos/uso terapéutico , Interferón-alfa/uso terapéutico , Micosis Fungoide/tratamiento farmacológico , Terapia PUVA , Adulto , Anciano , Anciano de 80 o más Años , Terapia Combinada , Supervivencia sin Enfermedad , Femenino , Humanos , Interferón alfa-2 , Masculino , Persona de Mediana Edad , Micosis Fungoide/patología , Estadificación de Neoplasias , Estudios Prospectivos , Proteínas Recombinantes , Inducción de Remisión , Resultado del Tratamiento
16.
Cutis ; 59(5): 278-80, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9169271

RESUMEN

A 66-year-old man, admitted to the hospital for prostatic carcinoma, presented with a nodular lesion located on the presternal region and a small nodule (0.5 cm in diameter) simulating a scalp sebaceous cyst located on the scalp. Moreover, an irregular darkbrown lesion was observed on the left side of the abdomen, and a brownish macula was also present on the presternal region. Histologic examination of the two nodular lesions revealed cutaneous metastases from prostatic carcinoma. The pigmented lesion, localized on the abdomen, proved to be a superficial spreading melanoma with a maximal depth of 1.36 mm. Histologic examination of the brownish lesion on the presternal region revealed nevus cell nests within the epidermis and in the dermis. We discuss the propensity of developing a secondary cancer in a patient with a primary malignancy.


Asunto(s)
Adenocarcinoma/secundario , Melanoma/patología , Neoplasias Primarias Múltiples , Nevo/patología , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/secundario , Abdomen , Adenocarcinoma/patología , Anciano , Humanos , Neoplasias Pulmonares/secundario , Masculino , Neoplasias de la Próstata/patología , Cuero Cabelludo , Tórax
17.
Dermatology ; 195(3): 289-92, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9407185

RESUMEN

Lymphoblastic lymphoma (LBL) is a neoplasm of lymphoid precursors presenting usually as acute leukemia with bone marrow and peripheral blood involvement. Primary cutaneous involvement of LBL with a pre-B phenotype has to be considered an extremely uncommon occurrence, accounting for less than 1% of all non-Hodgkin lymphomas. A child with an LBL involving a single cutaneous manifestation of 6 months duration is presented. At the time of presentation, the lesion consisted of a rapidly enlarging deeply infiltrated tumor on the upper arm. Immunophenotypic analysis performed an paraffin-embedded and frozen tissue sections revealed 2 pre-B phenotype of the tumor cells. Similar results were obtained from lymph node and bone marrow biopsy specimens. After 26 months of polychemotherapy, the patient is currently in complete remission. We wish to add this case to the current literature of LBL with cutaneous involvement, emphasizing the importance of a correct diagnosis and the excellent response to the therapeutic regimen.


Asunto(s)
Leucemia-Linfoma Linfoblástico de Células Precursoras/patología , Neoplasias Cutáneas/patología , Linfocitos B , Quimioterapia Combinada , Femenino , Humanos , Inmunofenotipificación , Lactante , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Inducción de Remisión , Neoplasias Cutáneas/tratamiento farmacológico
18.
Ann Dermatol Venereol ; 121(4): 319-21, 1994.
Artículo en Francés | MEDLINE | ID: mdl-7702251

RESUMEN

We observed a case of folliculitis decalvans involving the beard and the scalp with a tufted hair folliculitis aspect in the occipital region. The presence of two clinical presentations in the same patient has not been reported in the literature. This would suggest that the two entities could be morphological aspects of the same pathological process which might cause either atrophy with loss or the annexes or tufted hair folliculitis depending upon the depts and destructive capacity of the inflammatory process.


Asunto(s)
Foliculitis/patología , Enfermedades del Cabello/patología , Dermatosis del Cuero Cabelludo/patología , Anciano , Humanos , Masculino
19.
Minerva Chir ; 48(11): 649-52, 1993 Jun 15.
Artículo en Italiano | MEDLINE | ID: mdl-8414107

RESUMEN

The results of a clinico-pathologic and immunohistochemical study of an angiomatoid malignant fibrous histiocytoma are reported. This lesion is an uncommon tumor of the superficial soft tissue, of low-grade malignancy, typical of adolescence and early adult life. The patient, a 10-year-old female, presented with a mass of the left popliteal fossa, treated with surgical excision of the tumor and the surrounding cutaneous and subcutaneous tissue. The tumor was a well-circumscribed, firm nodule measuring 2.5 x 1.0 cm. Histologically, it showed aggregates of spindled and rounded cells often lining cystic cavities filled with blood. The immunohistochemical analysis revealed a cytoplasmatic immunoreactivity for KP1 (CD68), which was taken as indicating that the tumoral mesenchymal cells had acquired phagocytic capacities. The patient is well without signs of local recurrence or metastatic disease 4 years after the surgical treatment. The case reported confirms that appropriate local surgery is the elective therapy for this type of soft tissue tumor.


Asunto(s)
Histiocitoma Fibroso Benigno/patología , Rodilla , Neoplasias de los Tejidos Blandos/patología , Niño , Femenino , Humanos , Inmunohistoquímica
20.
Pathologica ; 84(1092): 511-6, 1992.
Artículo en Italiano | MEDLINE | ID: mdl-1491892

RESUMEN

Granulomatous hepatitis make up a group of conditions of various aetiologies. The diagnosis of granulomatous hepatitis is histologic, since the aspect of the granulomatous lesion is not always indicative of a specific disease. It is important to take into consideration for the aetiologic diagnosis a good response to a specific therapy or the execution of complementary examinations. The 25% of granulomatous hepatitis remain undiagnosed.


Asunto(s)
Entamebiasis/patología , Granuloma/patología , Hepatitis/patología , Hígado/patología , Animales , Anticuerpos Antiprotozoarios/sangre , Niño , Entamoeba histolytica/inmunología , Entamebiasis/complicaciones , Entamebiasis/diagnóstico , Entamebiasis/tratamiento farmacológico , Femenino , Fiebre de Origen Desconocido/etiología , Granuloma/parasitología , Hepatitis/parasitología , Humanos , Metronidazol/uso terapéutico , Necrosis , Supuración
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA